Oseltamivir treatment for influenza in hospitalized children without underlying diseases

Pediatric Infectious Disease Journal

Volumn 32, Issue 10, 2013, Pages 1066-1069

  Bueno, Mercedes ^a   Calvo, Cristina ^b   Méndez Echevarría, Ana ^c   De José, María Isabel ^c   Santos, Mar ^d   Carrasco, Jaime ^e   Tovizi, Miriann ^f   Guillén, Sara ^g   De Blas, Ana ^h   Llorente, Marta ⁱ   Tarrago, Alfredo ^j   Escosa, Luis ^c   Cilleruelo, María José ^e   Tomatis, Cristina ^d   Blazquez, Daniel ^f   Otheo, Enrique ^h   Mazagatos, Diana ^a   García García, Maria Luz ^b  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^b HOSPITAL SEVERO OCHOA   (Spain)

^c HOSPITAL INFANTIL LA PAZ   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^h HOSPITAL RAMÓN Y CAJAL   (Spain)

ⁱ Hospital Del Sureste   (Mexico)

^j HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

more..

Author keywords

Hospitalized children; Influenza; Oseltamivir

Indexed keywords

ANTIBIOTIC AGENT; OSELTAMIVIR; OXYGEN;

ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTICLE; ASTHMA; BACTERIAL PNEUMONIA; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; HYPOXIA; INFLUENZA; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OXYGEN THERAPY; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SPAIN; TREATMENT OUTCOME; URTICARIA; VOMITING;

ANALYSIS OF VARIANCE; ANTIVIRAL AGENTS; CHI-SQUARE DISTRIBUTION; CHILD, PRESCHOOL; FEMALE; FEVER; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA, HUMAN; LENGTH OF STAY; MALE; OSELTAMIVIR; RETROSPECTIVE STUDIES;

EID: 84891825696     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31829be4bc     Document Type: Article

References (33)

1. Nair H, Brooks WA, Katz M, et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and metaanalysis. Lancet. 2011;378: 1917-1930.
2. Dawood FS, Jain S, Finelli L, et al; Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360: 2605-2615.
3. Bautista E, Chotpitayasunondh T, Gao Z, et al Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010;362: 1708-1719.
4. Centers for Disease Control and Prevention (CDC). Emergency Use Authorization of Tamiflu (oseltamivir). Available at: http://www.cdc. gov/h1n1flu/eua/tamiflu.htm. Accessed February 2, 2013.
5. American Academy of Pediatrics Committee on Infectious Diseases. Antiviral therapy and prophylaxis for influenza in children. Pediatrics. 2007;119: 852-860.
6. Committee on Infectious Diseases. Recommendations for prevention and control of influenza in children, 2012-2013. Pediatrics. 2012;130: 780-792.
7. Barr CE, Schulman K, Iacuzio D, Bradley JS. Effect of oseltamivir on the risk of pneumonia and use of health care services in children with clinically diagnosed influenza. Curr Med Res Opin. 2007;23: 523-531.
8. Chan-Tack KM, Murray JS. Antiviral therapy and outcomes in hospitalized patients with influenza. Clin Infect Dis. 2008;46: 1628-1629; author reply 1629.
9. Coffin SE, Leckerman K, Keren R, et al. Oseltamivir shortens hospital stays of critically ill children hospitalized with seasonal influenza: a retrospective cohort study. Pediatr Infect Dis J. 2011;30: 962-966.
10. del Rosal T, Baquero-Artigao F, Calvo C, et al. Pandemic H1N1 influenzaassociated hospitalizations in children in Madrid, Spain. Influenza Other Respi Viruses. 2011;5:e544-e551.
11. Fallo AA, Contrini MM, Neyro S, et al. Case characteristics and use of oseltamivir in children and household contacts. Pediatr Infect Dis J. 2012;31: 781-783.
12. Heinonen S, Silvennoinen H, Lehtinen P, et al. Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial. Clin Infect Dis. 2010;51: 887-894.
13. Hernán MA, Lipsitch M. Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials. Clin Infect Dis. 2011;53: 277-279.
14. Launes C, García-García JJ, Jordán I, et al. 2009 Influenza A H1N1 infections: delays in starting treatment with oseltamivir were associated with a more severe disease. Pediatr Infect Dis J. 2011;30: 622-625.
15. Wang K, Shun-Shin M, Gill P, et al. Neuraminidase inhibitors for preventing and treating influenza in children. Cochrane Database Syst Rev. 2012;1:CD002744.
16. Le QM, Wertheim HF, Tran ND, et al; Vietnam H1N1 Investigation Team. A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N Engl J Med. 2010;362: 86-87.
17. Smith JR, Rayner CR, Donner B, et al. Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience. Adv Ther. 2011;28: 927-959.
18. Moore C, Galiano M, Lackenby A, et al. Evidence of person-to-person transmission of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus in a hematology unit. J Infect Dis. 2011;203: 18-24.
19. Hernández-Bou S, Novell CB, Alins JG, et al Infectious Diseases Working Group, Spanish Society of Pediatric Emergencies. Hospitalized children with influenza A H1N1 (2009) infection: a Spanish multicenter study. Pediatr Emerg Care. 2013;29: 49-52.
20. Flood RG, Badik J, Aronoff SC. The utility of serum C-reactive protein in differentiating bacterial from nonbacterial pneumonia in children: a metaanalysis of 1230 children. Pediatr Infect Dis J. 2008;27: 95-99.
21. Michelow IC, Lozano J, Olsen K, et al. Diagnosis of Streptococcus pneumoniae lower respiratory infection in hospitalized children by culture, polymerase chain reaction, serological testing, and urinary antigen detection. Clin Infect Dis. 2002;34:E1-E11.
22. American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement - recommendations for prevention and control of influenza in children, 2010-2011. Pediatrics. 2010;126: 816-826.
23. Mares J, Rodrigo C, Moreno-Perez D, et al. Recommendations for the management of influenza in pediatrics (2009-2010). An Pediatr (Barc). [published online ahead of print February 2, 2010]. doi: 10.1016/j. anpedi.2009.12.001.
24. Sato M, Hosoya M, Kato K, et al. Viral shedding in children with influenza virus infections treated with neuraminidase inhibitors. Pediatr Infect Dis J. 2005;24: 931-932.
25. Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J. 2001;20: 127-133.
26. Poulakou G, Souto J, Balcells J, et al. First influenza season after the 2009 pandemic influenza: characteristics of intensive care unit admissions in adults and children in Vall d'Hebron Hospital. Clin Microbiol Infect. 2012;18: 374-380.
27. Katsunuma T, Matsui T, Iwata T, et al. Hospitalizations associated with pandemic influenza A (H1N1) 2009 in asthmatic children in Japan. Allergol Int. 2012;61: 75-82.
28. Calvo Rey C, Garcia Garcia ML, Casas Flecha I, Martin del Valle F, Centeno Jimenez M, Perez-Brena P. Influenza virus infections in infants aged less than two years old. An Pediatr (Barc). 2005;63: 22-28.
29. Siedler K, Skopnik H. Oseltamivir for treatment of influenza in infants less than one year: a retrospective analysis. Pediatr Infect Dis J. 2010;29: 495-498.
30. Peltola V, Reunanen T, Ziegler T, et al. Accuracy of clinical diagnosis of influenza in outpatient children. Clin Infect Dis. 2005;41: 1198-1200.
31. Stephenson I, Democratis J, Lackenby A, et al. Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children. Clin Infect Dis. 2009;48: 389-396.
32. Tamura D, Sugaya N, Ozawa M, et al. Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors. Clin Infect Dis. 2011;52: 432-437.
33. Hurt AC, Chotpitayasunondh T, Cox NJ, et al; WHO Consultation on Pandemic Influenza A (H1N1) 2009 Virus Resistance to Antivirals. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis. 2012;12: 240-248.